Total Funding
56
53
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
85697
Abterra Biosciences uses technology to map the antibody response, and rapidly identify better therapeutic antibodies.
Anand Patel: CTO- Anand Patel: CTO
About the Company
Abterra Biosciences provides technologies that use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response, and rapidly identify better therapeutic antibodies. Abterra Biosciences assembles an interdisciplinary team of data scientists and biologists to reimagine the
development of antibody therapeutics. Alicanto, a novel antibody discovery platform developed by Abterra Biosciences, identifies target-specific antibodies in serum. It identifies high-affinity antibodies without the need for time-consuming and inefficient cell selection, fusions, or cloning.
Women Led
